Ono Pharmaceutical Balance Sheet Health
Financial Health criteria checks 6/6
Ono Pharmaceutical has a total shareholder equity of ¥798.6B and total debt of ¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are ¥913.7B and ¥115.1B respectively. Ono Pharmaceutical's EBIT is ¥160.3B making its interest coverage ratio -46.5. It has cash and short-term investments of ¥204.6B.
Key information
0%
Debt to equity ratio
JP¥0
Debt
Interest coverage ratio | -46.5x |
Cash | JP¥204.60b |
Equity | JP¥798.61b |
Total liabilities | JP¥115.06b |
Total assets | JP¥913.67b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 4528's short term assets (¥413.6B) exceed its short term liabilities (¥103.6B).
Long Term Liabilities: 4528's short term assets (¥413.6B) exceed its long term liabilities (¥11.4B).
Debt to Equity History and Analysis
Debt Level: 4528 is debt free.
Reducing Debt: 4528 had no debt 5 years ago.
Debt Coverage: 4528 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 4528 has no debt, therefore coverage of interest payments is not a concern.